Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Decreases and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Tiziana Life Sciences Ltd’s current trading price is -5.38% away from its 52-week high, while its distance from the 52-week low is 290.79%. The stock’s price range for this period has been between $0.63 and $2.60 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.15 million for the day, a number notably higher than the average daily volume of 0.34 million over the last three months.

The stock of Tiziana Life Sciences Ltd (TLSA) is currently priced at $2.46. In the last session, the stock climbed significantly, topping out at $7.96 after opening at $2.46. The day’s lowest price was $7.96 before the stock closed at $2.2.

The market performance of Tiziana Life Sciences Ltd’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $2.60 on 08/01/25, while the lowest value for the same duration was $0.63 on 12/31/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Tiziana Life Sciences Ltd (TLSA) has experienced a quarterly rise of 56.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 274.19M and boasts a workforce of 9 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.47, with a change in price of +0.94. Similarly, Tiziana Life Sciences Ltd recorded 373,290 in trading volume during the last 100 days, posting a change of +61.84%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TLSA stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.00.

TLSA Stock Stochastic Average

Tiziana Life Sciences Ltd’s raw stochastic average for the past 50 days is presently 89.23%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 88.03%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 70.09% and 68.47%, respectively.

TLSA Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 75.71% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 261.76%. Over the past 30 days, the price of TLSA has fallen by 66.22%. And in the last five days, it has surged by 0.41%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.